ArticleCureus2026
Malignancy Presenting As Recurrent Empyema: A Report of Two Cases and a Systematic Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung malignancy presenting as empyema is a rare presentation, which is commonly associated with infection. We report two patients initially diagnosed with tuberculosis-associated pleural disease who were subsequently confirmed to have lung malignancy. The first case involved a woman in her 40s presenting with progressive dyspnea, hydropneumothorax, persistent exudative pleural drainage, and prolonged air leak despite anti-tuberculosis therapy. Repeated cytological and microbiological examinations were negative, while persistently low pleural adenosine deaminase (ADA) levels and lack of clinical improvement prompted thoracotomy biopsy, which confirmed adenocarcinoma. The second case involved a man in his 40s presenting with persistent empyema during tuberculosis treatment. Despite thoracotomy and decortication, the patient continued to develop progressive respiratory and systemic symptoms. Subsequent imaging demonstrated a chest wall mass and vertebral lytic lesions suggestive of metastatic disease, while histopathological examination confirmed squamous cell carcinoma. A systematic search of PubMed, Cochrane, ProQuest, and Wiley databases up to May 5, 2026, identified eight published cases of lung malignancy presenting as empyema. Clinical presentation was frequently non-specific, although several patients exhibited red flag features such as hemoptysis, weight loss, and anorexia. Laboratory findings were not sufficiently specific to distinguish malignancy-associated empyema from infectious etiologies. Computed tomography frequently revealed findings suggestive of underlying malignancy, including lung masses, mediastinal lymphadenopathy, bronchial obstruction, and invasion into adjacent structures. Initial investigations commonly supported an infectious diagnosis, while a definitive diagnosis was consistently established only after invasive tissue biopsy. Malignancy-associated empyema represents an important diagnostic pitfall, particularly in tuberculosis (TB)-endemic settings where infectious etiologies are strongly favored. Persistent or non-resolving empyema with atypical clinical, biochemical, or radiological findings should prompt early tissue biopsy to avoid delayed oncologic diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.